Miromatrix

Jeff Ross, Ph.D., CEO 

Oct. 12 | 3:30pm | Oxford Biomedica Ballroom 

Eden Prairie, MN 

(NASDAQ: MIRO) 

In-person Presentation 

Miromatrix is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives. The company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. Miromatrix’s initial development focus is on human livers and kidneys. 

www.miromatrix.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions